Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Novak

Showing results (711-720 of 826) with videos related to

Pageof 83
Sort By:
Blood|December 3, 2014
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaCristina Correia, Paula A Schneider, Haiming Dai, et al.
Science (New York, N.Y.)|November 30, 2004
Outbreak of West Nile virus in North AmericaA Spielman, T G Andreadis, C S Apperson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2013
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager, Sara J Achenbach, Yan W Asmann, et al.
International Journal of Epidemiology|October 13, 2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort StudyJames R Cerhan, Brian K Link, Thomas M Habermann, et al.
Blood Cancer Journal|July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphomaJanek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal|October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomasMelissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Haematologica|March 4, 2021
The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphomaJithma P Abeykoon, Paul J Hampel, Rebecca L King, et al.
Blood Cancer Discovery|July 16, 2025
IRF4 promotes immune evasion and shapes the tumor microenvironment in Follicular LymphomaSurendra Dasari, Kerstin Wenzl, Geoffrey M Nelson, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Stem Cells Translational Medicine|October 26, 2017
Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem CellsJung-Hyun Kim, Andreas Kurtz, Bao-Zhu Yuan, et al.
Pageof 83

Showing results (711-720 of 826) with videos related to

Sort By:
Pageof 83
Blood|December 3, 2014
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaCristina Correia, Paula A Schneider, Haiming Dai, et al.
Science (New York, N.Y.)|November 30, 2004
Outbreak of West Nile virus in North AmericaA Spielman, T G Andreadis, C S Apperson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2013
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager, Sara J Achenbach, Yan W Asmann, et al.
International Journal of Epidemiology|October 13, 2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort StudyJames R Cerhan, Brian K Link, Thomas M Habermann, et al.
Blood Cancer Journal|July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphomaJanek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal|October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomasMelissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Haematologica|March 4, 2021
The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphomaJithma P Abeykoon, Paul J Hampel, Rebecca L King, et al.
Blood Cancer Discovery|July 16, 2025
IRF4 promotes immune evasion and shapes the tumor microenvironment in Follicular LymphomaSurendra Dasari, Kerstin Wenzl, Geoffrey M Nelson, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Stem Cells Translational Medicine|October 26, 2017
Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem CellsJung-Hyun Kim, Andreas Kurtz, Bao-Zhu Yuan, et al.
Pageof 83